The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2 - News-Medical.Net

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2 - News-Medical.Net
In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependen…
Several prophylactic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being used across the globe to control the spread of the COVID-19 pandemic. However, a successful contro… [+6757 chars] Read More



Related Stories

See All